
Johnson & Johnson’s Animas Corporation will cease business and close operations after the pharma giant could not find a buyer …

Dr Áine McCarthy, Senior Science Information Officer at Cancer Research UK, discusses the latest efforts to further understand the immunotherapies …

Roche has revealed that the FDA has given approval to its cobas Zika test to determine whether a blood sample …

Part of Obama’s Affordable Care Act included the provision that employer-provided health insurance must cover birth control, President Trump has …

In a bid to speed up access to medicines for patients, China has revealed it intends to incorporate data from …

The FDA has announced the approval of a new form of treatment for central sleep apnea, in the form of …

Sanofi has promoted Stefan Oelrich to the position of Executive Vice President of Diabetes and Cardiovascular (DCV), giving him a …

AbbVie has been stung with a $140 million damages award to a man that suffered a heart attack after using …

New damning allegations have arisen concerning Afghanistan’s pharmaceutical industry, as the Medicine Importers Union claims that at least 40% of …

Bayer, and development partner Janssen, have been forced to stop a Phase 3 trial looking at expanding the indication of …

South Africa’s Competition Commission has admitted that there is no case to be heard against Aspen and Equity, in regards …

Merck KGaA has installed a new head of its healthcare business for the Middle East, Africa and Turkey (MEA) region, …

The ABPI has been knocked back by the UK High Court in its legal challenge to NICE over new drug …

Dr Deborah O’Neil, Chief Executive and Scientific Officer at NovaBiotics, discusses the WHO-recognised threat of ‘super gonorrhoea’ and the antimicrobial …

KSQ Therapeutics has been known of for the last two years, when it was originally founded, but now it has …